QQ客服 官方微博 反馈留言

浏览/检索结果: 共17条，第1-10条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and tolerability profile of raltitrexed in Chinese patients with locally advanced or recurrent and metastatic colorectal cancer: A phase IV trial. 会议论文 作者:  Qin, Shukui;  Li, Jin;  Liu, Yunpeng;  Chen, Yin;  Xu, Nong 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study 会议论文 作者:  Huang, Jianjin;  Jian, Hong;  Li, Wei;  Ma, Zhiyong;  Feng, Jifeng 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 lung adenocarcinoma  gefitinib  chemotherapy   Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study 会议论文 作者:  Jian, Hong;  Li, Wei;  Ma, Zhiyong;  Huang, Jianjin;  Feng, Jifeng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13 lung adenocarcinoma  gefitinib  chemotherapy   An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial 会议论文 作者:  Shi, Yuankai;  Wang, Mengzhao;  He, Jianxing;  Chang, Jianhua;  Han, Baohui 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19 S-1  phase 3 trial  Therapy  NSCLC   Post-hoc analyses of overall survival (OS) and progression-free survival (PFS) in the TRIO-013/LOGiC trial of lapatinib (L) in combination with capecitabine plus oxaliplatin (CapeOx) 会议论文 作者:  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Choel;  Xu, Jian-Ming;  Park, Joon Oh 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19 Intercalating and maintenance use of gefitinib plus chemotherapy versus chemotherapy alone in selected advanced NSCLC(ISCAN,CTONG-1102): A multicentre, open-label, randomised, phase 3 study. 会议论文 作者:  Lu, Shun;  Jian, Hong;  Li, Wei;  Yong, Ma Zhi;  Huang, Jian Jin 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/19 An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Hypertension and myelosuppression as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文 作者:  Qin, Shukui;  Jin, Jie;  Guo, Jun;  Wang, Jin-Wan;  Zhou, Fang-Jian 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Patient-reportedOutcomesinaRegistrationalStudyofAxitiniborSorafenibasSecond-lineTherapyinAsianPatientswithMetastaticRenalCellCarcinoma 会议论文 作者:  Shukui Qin;  Feng Bi;  Jie Jin;  Ying Cheng;  Jun Guo 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19